Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.55 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.55 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.55 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.55 |
| ▸ | CDA | P32320 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | MTOR | P42345 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.52 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.52 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.52 |
| ▸ | PYGM | P11217 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7023707 | 1.00 | SLC28A1 (0.55) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL24487856 | 0.86 | CDA (0.51) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL2845039 | 0.80 | CDA (0.51) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL14570585 | 0.80 | MAPT (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL7033026 | 0.80 | MAPT (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL5954124 | 0.80 | MAPT (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL10243962 | 0.80 | MAPT (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL28163188 | 0.79 | MAPT (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL28049721 | 0.79 | MAPT (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3CDA | |
| SCHEMBL28121628 | 0.79 | MAPT (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3CDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| US-20230365970-A1 | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof | ALIGOS THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230332153-A1 | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof | ALIGOS THERAPEUTICS, INC. (US) | 2023-10-19 | — | — | US | disclosed |
| US-20030144489-A1 | Method for screening nucleic acid catalysts | RIBOZYME PHARMACEUTICALS, INC. | 2003-07-31 | — | — | US | disclosed |
| EP-1321521-A1 | Ribozymes directed against flt-1 | RIBOZYME PHARMACEUTICALS, INC. (US) | 2003-06-25 | — | — | EP | disclosed |
| US-6548657-B1 | Synthesis of ribozyme libraries and gene sequences | RIBOZYME PHARMACEUTICALS, INC. | 2003-04-15 | — | — | US | disclosed |
| US-6280936-B1 | USEFUL FOR CLEAVAGE OF RIBONUCLEIC ACID (RNA) AND DEOXYRIBONUCLEIC ACID | RIBOZYME PHARMACEUTICALS, INC. | 2001-08-28 | — | — | US | disclosed |
| WO-1998050530-A9 | ENZYMATIC NUCLEIC ACIDS: SYNTHESIS, SELECTION AND USE | RIBOZYME PHARM INC (US) | 1999-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365970-A1 | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof | NSUN2, SNRPA, SNRPF | SLC28A1 204/4885SLC28A2 183/4885SLC29A1 666/4885 |
| US-20230332153-A1 | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof | NSUN2, SNRPA, SNRPF | SLC28A1 204/4885SLC28A2 183/4885SLC29A1 666/4885 |
| US-20030144489-A1 | Method for screening nucleic acid catalysts | POLM, POLRMT, RNGTT | SLC28A1 1028/4885SLC28A2 893/4885SLC29A1 677/4885 |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | SLC28A1 2343/4885SLC28A2 2401/4885SLC29A1 1381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.